MX2014010873A - Batches of recombinant adenovirus with altered terminal ends. - Google Patents

Batches of recombinant adenovirus with altered terminal ends.

Info

Publication number
MX2014010873A
MX2014010873A MX2014010873A MX2014010873A MX2014010873A MX 2014010873 A MX2014010873 A MX 2014010873A MX 2014010873 A MX2014010873 A MX 2014010873A MX 2014010873 A MX2014010873 A MX 2014010873A MX 2014010873 A MX2014010873 A MX 2014010873A
Authority
MX
Mexico
Prior art keywords
batches
recombinant adenovirus
terminal ends
adenovirus
recombinant
Prior art date
Application number
MX2014010873A
Other languages
Spanish (es)
Other versions
MX352456B (en
Inventor
Jerome H H V Custers
Jort Vellinga
Original Assignee
Crucell Holland Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crucell Holland Bv filed Critical Crucell Holland Bv
Priority claimed from PCT/EP2013/054846 external-priority patent/WO2013135615A1/en
Publication of MX2014010873A publication Critical patent/MX2014010873A/en
Publication of MX352456B publication Critical patent/MX352456B/en

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention provides a composition comprising a plurality of recombinant adenovirus particles, being a recombinant human adenovirus of serotype 5, 26, 34, 35, 48,49 or 50, or a recombinant simian adenovirus, characterized in that the genomes of essentially all adenovirus particles in said composition comprise as the 5' terminal nucleotides the nucleotide sequence: CTATCTAT. The invention also provides methods to produce such compositions.
MX2014010873A 2012-03-12 2013-03-11 Batches of recombinant adenovirus with altered terminal ends. MX352456B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261609678P 2012-03-12 2012-03-12
EP12159009 2012-03-12
PCT/EP2013/054846 WO2013135615A1 (en) 2012-03-12 2013-03-11 Batches of recombinant adenovirus with altered terminal ends

Publications (2)

Publication Number Publication Date
MX2014010873A true MX2014010873A (en) 2014-12-10
MX352456B MX352456B (en) 2017-11-24

Family

ID=52824797

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014010873A MX352456B (en) 2012-03-12 2013-03-11 Batches of recombinant adenovirus with altered terminal ends.

Country Status (4)

Country Link
HK (1) HK1206385A1 (en)
HR (1) HRP20160825T1 (en)
MX (1) MX352456B (en)
ZA (1) ZA201405826B (en)

Also Published As

Publication number Publication date
HK1206385A1 (en) 2016-01-08
ZA201405826B (en) 2015-12-23
HRP20160825T1 (en) 2016-08-26
MX352456B (en) 2017-11-24

Similar Documents

Publication Publication Date Title
NZ628385A (en) Batches of recombinant adenovirus with altered terminal ends
JOP20180102B1 (en) Pharmaceutical composition
WO2015138357A3 (en) Compositions useful in treatment of otc deficency
MX344972B (en) Immunostimulatory oligonucleotides.
PH12017501583A1 (en) Novel proteins specific for cd137
PH12014502347A1 (en) Composition and methods for highly efficient gene transfer using aav capsid variants
MX2020004986A (en) Improved compositions for treating muscular dystrophy.
MX2018016021A (en) Compositions and methods comprising a lipolytic enzyme variant.
BR112014026758A2 (en) serpinc1 irna compositions and methods for using them
MX2017009767A (en) Novel proteins specific for angiogenesis.
MX2016008448A (en) Var2csa-drug conjugates.
MX2017001290A (en) Fabric treatment composition comprising an aminosiloxane polymer nanoemulsion.
MX2013004061A (en) Cyclosporin analogs.
MX364814B (en) Bridged bicyclic nucleosides.
EA201590491A1 (en) IMMUNOGENIC COMPOSITION
JO3154B1 (en) Trpv4 antagonists
UA112549C2 (en) Polyacrylate-based active compound-comprising particles
MX2013004062A (en) Cyclosporin analogs.
IN2015DN03206A (en)
WO2011100330A3 (en) Compositions and methods for preventing or treating a human parvovirus infection
MX2015012905A (en) Recombinant factor viii formulations.
MX2014006574A (en) Acamprosate formulations, methods of using the same, and combinations comprising the same.
EP2569327A4 (en) Eif4e binding peptides
UA117563C2 (en) Composition for treating cancer associated with hpv infection
MX352456B (en) Batches of recombinant adenovirus with altered terminal ends.

Legal Events

Date Code Title Description
FG Grant or registration